Weigang He

982 total citations
14 papers, 761 citations indexed

About

Weigang He is a scholar working on Molecular Biology, Immunology and Epidemiology. According to data from OpenAlex, Weigang He has authored 14 papers receiving a total of 761 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Immunology and 3 papers in Epidemiology. Recurrent topics in Weigang He's work include Immune Response and Inflammation (5 papers), Pharmacological Effects of Natural Compounds (3 papers) and Sphingolipid Metabolism and Signaling (3 papers). Weigang He is often cited by papers focused on Immune Response and Inflammation (5 papers), Pharmacological Effects of Natural Compounds (3 papers) and Sphingolipid Metabolism and Signaling (3 papers). Weigang He collaborates with scholars based in China, United States and Canada. Weigang He's co-authors include Xuetao Cao, Nan Li, Wei Chen, Li Wang, Qiuyan Liu, Yuejuan Zheng, Xin Jiang, Qingwen Zhang, Jinxia Sun and Xinru Jiang and has published in prestigious journals such as Cancer Research, Scientific Reports and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Weigang He

14 papers receiving 754 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weigang He China 12 340 312 153 134 92 14 761
Elizabeth Meals United States 15 289 0.8× 259 0.8× 118 0.8× 193 1.4× 69 0.8× 25 797
Rodolfo Thomé Brazil 20 374 1.1× 368 1.2× 70 0.5× 120 0.9× 99 1.1× 46 1.1k
Eunkyung Song South Korea 18 203 0.6× 392 1.3× 110 0.7× 194 1.4× 94 1.0× 35 1.0k
Hyung‐Joon Kwon South Korea 13 347 1.0× 395 1.3× 69 0.5× 208 1.6× 115 1.3× 18 942
Yaping Yang China 18 311 0.9× 419 1.3× 203 1.3× 68 0.5× 33 0.4× 29 908
Emma Smith United Kingdom 11 315 0.9× 350 1.1× 174 1.1× 157 1.2× 111 1.2× 15 911
Mengyun Ke China 16 152 0.4× 270 0.9× 105 0.7× 113 0.8× 132 1.4× 32 697
Lei Zhu China 18 135 0.4× 609 2.0× 149 1.0× 110 0.8× 117 1.3× 58 1.0k
Manhua Cui China 18 194 0.6× 591 1.9× 212 1.4× 83 0.6× 214 2.3× 55 984
Yue Luo China 15 164 0.5× 236 0.8× 75 0.5× 201 1.5× 90 1.0× 67 761

Countries citing papers authored by Weigang He

Since Specialization
Citations

This map shows the geographic impact of Weigang He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weigang He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weigang He more than expected).

Fields of papers citing papers by Weigang He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weigang He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weigang He. The network helps show where Weigang He may publish in the future.

Co-authorship network of co-authors of Weigang He

This figure shows the co-authorship network connecting the top 25 collaborators of Weigang He. A scholar is included among the top collaborators of Weigang He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weigang He. Weigang He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Deng, Wei, Min Cai, Dong Guo, et al.. (2024). Discovery of Sovleplenib, a Selective Inhibitor of Syk in Clinical Development for Autoimmune Diseases and Cancers. ACS Medicinal Chemistry Letters. 15(5). 595–601. 1 indexed citations
2.
Wu, Zhipeng, Weigang He, Xiaoming Dai, et al.. (2023). Preclinical Pharmacology Characterization of Sovleplenib (HMPL-523), an Orally Available Syk Inhibitor. Journal of Pharmacology and Experimental Therapeutics. 388(1). 156–170. 4 indexed citations
3.
Jiang, Xinru, Dan Liu, Ting Shi, et al.. (2020). Secoeudesma sesquiterpenes lactone A alleviates inflammation and offers adjuvant protection in severe infection of carbapenem-resistant Klebsiella pneumoniae. Journal of Ethnopharmacology. 252. 112605–112605. 11 indexed citations
4.
He, Weigang, et al.. (2020). Andrographolide exerts anti-inflammatory effects in Mycobacterium tuberculosis-infected macrophages by regulating the Notch1/Akt/NF-κB axis. Journal of Leukocyte Biology. 108(6). 1747–1764. 29 indexed citations
5.
Zhang, Qingwen, Jinxia Sun, Weigang He, et al.. (2020). Guttiferone K Exerts the Anti-inflammatory Effect on Mycobacterium Tuberculosis- (H37Ra-) Infected Macrophages by Targeting the TLR/IRAK-1 Mediated Akt and NF-κB Pathway. Mediators of Inflammation. 2020. 1–16. 11 indexed citations
6.
Kong, Rui, Nan Wang, Jingjing Li, et al.. (2018). Portulaca Extract Attenuates Development of Dextran Sulfate Sodium Induced Colitis in Mice through Activation of PPARγ. PPAR Research. 2018. 1–11. 30 indexed citations
7.
He, Weigang, Jing Ma, Xin Jiang, et al.. (2018). Ephedrine hydrochloride protects mice from staphylococcus aureus-induced peritonitis.. PubMed. 10(3). 670–683. 12 indexed citations
8.
Zhang, Qingwen, Xinru Jiang, Weigang He, et al.. (2017). MCL Plays an Anti-Inflammatory Role inMycobacterium tuberculosis-Induced Immune Response by Inhibiting NF-κB and NLRP3 Inflammasome Activation. Mediators of Inflammation. 2017. 1–12. 36 indexed citations
9.
Zhang, Qingwen, Jinxia Sun, Yuli Wang, et al.. (2017). Antimycobacterial and Anti-inflammatory Mechanisms of Baicalin via Induced Autophagy in Macrophages Infected with Mycobacterium tuberculosis. Frontiers in Microbiology. 8. 2142–2142. 104 indexed citations
10.
Jiang, Xinru, Yuli Wang, Yifei Qin, et al.. (2017). Micheliolide provides protection of mice against Staphylococcus aureus and MRSA infection by down-regulating inflammatory response. Scientific Reports. 7(1). 41964–41964. 48 indexed citations
11.
Qin, Xiangyang, Xinru Jiang, Xin Jiang, et al.. (2016). Micheliolide inhibits LPS-induced inflammatory response and protects mice from LPS challenge. Scientific Reports. 6(1). 23240–23240. 104 indexed citations
12.
Zheng, Yuejuan, Ziyi Guo, Weigang He, et al.. (2012). Ephedrine hydrochloride protects mice from LPS challenge by promoting IL-10 secretion and inhibiting proinflammatory cytokines. International Immunopharmacology. 13(1). 46–53. 48 indexed citations
13.
Li, Nan, Yuanyuan Zheng, Wei Chen, et al.. (2007). Adaptor Protein LAPF Recruits Phosphorylated p53 to Lysosomes and Triggers Lysosomal Destabilization in Apoptosis. Cancer Research. 67(23). 11176–11185. 51 indexed citations
14.
He, Weigang, Qiuyan Liu, Li Wang, et al.. (2007). TLR4 signaling promotes immune escape of human lung cancer cells by inducing immunosuppressive cytokines and apoptosis resistance. Molecular Immunology. 44(11). 2850–2859. 272 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026